Efficacy of using roncoleukin in combined therapy of experimental trichinellosis in mice

It is established on a model of experimental trichinellosis in mice that roncoleukin (rIL2) in a dose of 10000 IU/kg causes an increase in nonspecific resistance of the organism to invasion. A tendency of potentiation of the anthelmintic action of albendazole and reliable increase of the level of specific antibodies in blood serum is revealed when… CONTINUE READING